Sarepta Therapeutics Inc

The current institutional shareholding score of Sarepta Therapeutics Inc is 10.00, ranking 1 out of 157 in the Pharmaceuticals industry. The latest institutional shareholding proportion is 90.53%, representing a quarter-over-quarter increase of 4.25%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 1.58% of shares outstanding, with 0.18% increase in holdings.